Table 4.

Outcome measures of studies included in the systematic review.

Outcome	Domain	Subdomain	Tool	Pre-Based	Prom-Based	References
Medical Benefit	Functional Capacity	Endurance	6 min Walk Distance	x		[8,21,22,23,24,26,27,29,30,31,32,33,34,35,37,38,39,40,41]
			Endurance shuttle walk test	x		[33]
		Physical Activity	Actigraph	x		[8,21,24,27,33,34,37,40,41]
			Physical Activity Level		x	[40]
			Incremental Shuttle Walking Test	x		[33]
			Functional Performance Inventory—Short Form		x	[33]
		BMI	Weight × height2	x		[21,22,30]
		Strength	Quadricep force	x		[29,34]
			Triceps force	x		[29]
		Breath	Modified Medical Research Council dyspnea scale		x	[8,22,24,25,27,28,30,32,33,34,35,39]
			San Diego Shortness of Breath Questionnaire		x	[41]
			Spirometry values (i.e., FEV1, FVC)	x		[21,22,23,24,28,30,31,33,35,36,37,39]
	Participation	Quality of Life	St George’s Hospital Respiratory Questionnaire		x	[8,25,30,31,35,37]
			COPD-CAT		x	[8,24,26,30,33,34,36,39,40]
			Chronic Respiratory Questionnaire		x	[21,24,27,32,33,38]
			EuroQol 5-Dimension Questionnaire		x	[40]
			36-Item Short-Form Health Survey		x	[38,41]
			Clinical COPD Questionnaire		x	[29,40]
			IADL		x	[37,39]
		Mood	Hospital Anxiety and Depression Scale		x	[26,30,32,33,40]
			Profile of Mood States-Short Form		x	[41]
			General Anxiety Disorder Score		x	[37]
			Beck Depression Inventory		x	[39]
			State-trait Anxiety Inventory		x	[39]
		Self-Efficacy	Exercise Self-Regulatory Efficacy Scale		x	[25]
			Self-Efficacy for Managing Chronic Disease 6-Item Scale		x	[41]
			Alberto Chronic Obstructive Pulmonary Disease Self-Care Behavior Inventory		x	[41]
			Pulmonary Rehabilitation Adapted Index of Self-Efficacy		x	[32,33]
		Social Support	MOS Social Support Survey		x	[41]
	Mortality	-	N Deaths			[40]
	Morbidity	-	COPD-specific COmorbidity TEst		x	[32]
			Exacerbation history and comorbidity		x	[34]
Patient-Relevant	Adherence	-	N sessions/expected N sessions × 100	x		[8]
			N sessions performed	x		[23,26,33,37,41]
			Time dedicated to tasks	x		[41]
			Work rate/exercise time (s)	x		[33]
			N participants who complied with treatment (at least 8 consecutive weeks)	x		[38]
	Safety	-	Adverse events and hospitalizations		x	[26,34,35,37,38,39,41]
			Frequency of ED visits, outpatient clinic visits		x	[39,41]
			Open-ended questions		x	[41]